Maravai LifeSciences Holdings, Inc.
MRVI
$4.15
-$0.14-3.26%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 204.73M | 185.74M | 192.44M | 219.83M | 241.86M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 204.73M | 185.74M | 192.44M | 219.83M | 241.86M |
| Cost of Revenue | 143.06M | 150.05M | 151.90M | 152.71M | 151.67M |
| Gross Profit | 61.67M | 35.69M | 40.54M | 67.12M | 90.19M |
| SG&A Expenses | 133.45M | 143.92M | 154.78M | 158.47M | 160.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 292.91M | 311.37M | 324.85M | 330.22M | 331.19M |
| Operating Income | -88.18M | -125.63M | -132.42M | -110.39M | -89.34M |
| Income Before Tax | -188.81M | -234.97M | -218.04M | -345.03M | -291.76M |
| Income Tax Expenses | -4.53M | -4.21M | -4.23M | -3.82M | -1.97M |
| Earnings from Continuing Operations | -184.29 | -230.76 | -213.81 | -341.21 | -289.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 79.73M | 99.99M | 92.82M | 148.70M | 127.08M |
| Net Income | -104.56M | -130.77M | -121.00M | -192.52M | -162.71M |
| EBIT | -88.18M | -125.63M | -132.42M | -110.39M | -89.34M |
| EBITDA | -38.03M | -74.12M | -80.98M | -60.20M | -39.89M |
| EPS Basic | -0.72 | -0.91 | -0.84 | -1.35 | -1.15 |
| Normalized Basic EPS | 0.08 | 0.06 | -0.02 | 0.46 | 0.40 |
| EPS Diluted | -0.72 | -0.91 | -0.84 | -1.35 | -1.15 |
| Normalized Diluted EPS | 0.08 | 0.06 | -0.02 | 0.46 | 0.40 |
| Average Basic Shares Outstanding | 580.42M | 577.42M | 574.16M | 571.03M | 562.63M |
| Average Diluted Shares Outstanding | 580.42M | 577.42M | 574.16M | 571.03M | 562.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |